ABCL
Abcellera Biologics Inc
NASDAQ: ABCL · HEALTHCARE · BIOTECHNOLOGY
$3.82
-8.17% today
Updated 2026-04-29
Market cap
$1.16B
P/E ratio
—
P/S ratio
15.41x
EPS (TTM)
$-0.49
Dividend yield
—
52W range
$2 – $7
Volume
4.0M
Abcellera Biologics Inc (ABCL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.83M | $11.61M | $233.16M | $11.61M | $485.42M | $38.02M | $28.83M | $75.13M |
| Revenue growth (YoY) | — | +31.5% | +1907.9% | -95.0% | +4080.5% | -92.2% | -24.2% | +160.6% |
| Cost of revenue | $5.80M | $10.11M | $27.14M | $45.52M | $66.44M | $30.89M | $97.00M | — |
| Gross profit | $8.83M | $11.61M | $206.01M | $11.61M | $418.99M | $38.02M | $28.83M | $75.13M |
| Gross margin | 100.0% | 100.0% | 88.4% | 100.0% | 86.3% | 100.0% | 100.0% | 100.0% |
| R&D | $5.80M | $10.11M | $29.39M | $62.06M | $107.88M | $175.66M | $167.26M | $186.83M |
| SG&A | $2.15M | $2.75M | $11.91M | $2.75M | $55.48M | $61.00M | $72.71M | $83.23M |
| Operating income | $-753000.00 | $-4.12M | $156.03M | $-4.12M | $216.51M | $-237.21M | $-314.77M | $-217.10M |
| Operating margin | -8.5% | -35.5% | 66.9% | -35.5% | 44.6% | -623.8% | -1091.7% | -289.0% |
| EBITDA | $1.44M | $-155000.00 | $169.62M | $-154612.00 | $260.17M | $-192.16M | $-204.15M | $-155.42M |
| EBITDA margin | 16.3% | -1.3% | 72.7% | -1.3% | 53.6% | -505.3% | -708.0% | -206.9% |
| EBIT | $521000.00 | $-2.00M | $164.34M | $-2.00M | $227.06M | $-223.05M | $-301.15M | $-177.59M |
| Interest expense | $212000.00 | $209000.00 | $6.51M | $209196.00 | $4.04M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $309000.00 | $-2.21M | $118.92M | $-2.21M | $158.52M | $-146.40M | $-162.86M | $-146.41M |
| Net income growth (YoY) | — | -815.5% | +5478.5% | -101.9% | +7270.5% | -192.4% | -11.2% | +10.1% |
| Profit margin | 3.5% | -19.0% | 51.0% | -19.0% | 32.7% | -385.0% | -564.8% | -194.9% |